SynthesisAdvances in nutrition (Bethesda, Md.)2026
Impact of Plant-Based Drinks on Cardiometabolic Outcomes: A Systematic Review and Network Meta-analysis.
Synthesis in Advances in nutrition (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global demand for plant-based milk alternatives is rising, but their health effects compared with cow milk remain uncertain. Therefore, we conducted a systematic review and network meta-analysis (NMA) to compare different plant-based drinks with each other and with cow's milk on cardiometabolic outcomes. A systematic search was conducted in 3 electronic databases (MEDLINE, Cochrane CENTRAL, and Web of Science) and 2 trial registries. Randomized controlled trials (RCTs) with a minimum duration of 3 wk comparing different plant-based drinks (e.g., soy, rice, and oat) with another or with cow milk were included. We rated risk of bias using RoB 2.0 tool. Anthropometric outcomes, blood lipids, fasting glucose, and blood pressure were pooled using mean differences (MDs). NMAs were performed using a random-effects model. The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation approach. Fourteen RCTs involving 543 participants were included, comparing soy-, rice-, oat drinks, and cow milk. Overall, few differences were observed comparing plant-based drinks with another or with cow milk on cardiometabolic outcomes. Replacing 500 mL/d of cow's milk with soy drink may reduce low-density lipoprotein (LDL) cholesterol [MD: -0.47 mmol/L (-0.85; -0.10); low certainty], but showed no effect for high-density lipoprotein (HDL) cholesterol [MD: 0.01 mmol/L (-0.03; 0.05); moderate certainty]. Oat drink may slightly reduce total cholesterol compared with cow milk and rice drink [MD: -0.12 mmol/L (-0.24; -0.01); MD: -0.23 mmol/L (-0.40; -0.05)], but the evidence is very uncertain. Replacing 500 mL/d of cow milk with soy drink may reduce systolic and diastolic blood pressure [MD: -8.23 mmHg (-10.90; -5.55); MD: -7.82 mmHg (-13.61; -2.02); low certainty]. Our findings suggest that evidence for cardiometabolic differences between plant-based drinks and cow milk is limited. However, soy drink may lower blood pressure and LDL cholesterol compared with cow milk. The certainty of evidence was mainly low, highlighting the need for high-quality RCTs. This study was registered at PROSPERO as CRD42025638028.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.